These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9794741)

  • 1. Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome).
    Calò L; Sartore G; Bassi A; Basso C; Bertocco S; Marin R; Zambon S; Cantaro S; D'Angelo A; Davis PA; Manzato E; Crepaldi G
    J Hypertens; 1998 Jul; 16(7):1001-8. PubMed ID: 9794741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
    Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
    Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages.
    Suzukawa M; Abbey M; Howe PR; Nestel PJ
    J Lipid Res; 1995 Mar; 36(3):473-84. PubMed ID: 7775859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxes in magnesium transport in type 1 Bartter's syndrome and Gitelman's syndrome: a modeling analysis.
    Dutta P; Layton AT
    Am J Physiol Renal Physiol; 2024 Sep; 327(3):F386-F396. PubMed ID: 38991009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.
    Jialal I; Grundy SM
    Circulation; 1993 Dec; 88(6):2780-6. PubMed ID: 8252691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients.
    Beaudeux JL; Guillausseau PJ; Peynet J; Flourie F; Assayag M; Tielmans D; Warnet A; Rousselet F
    Clin Chim Acta; 1995 Aug; 239(2):131-41. PubMed ID: 8542651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
    Islam KN; O'Byrne D; Devaraj S; Palmer B; Grundy SM; Jialal I
    Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
    Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
    Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
    Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
    Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
    Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
    Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipid transfer activity and lipolysis on low density lipoprotein (LDL) oxidizability: evidence for lipolysis-generated non-esterified fatty acids as inhibitors of LDL oxidation.
    Viens L; Athias A; Lizard G; Simard G; Gueldry S; Braschi S; Gambert P; Lallemant C; Lagrost L
    J Lipid Res; 1996 Oct; 37(10):2179-92. PubMed ID: 8906595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health.
    Piolot A; Blache D; Boulet L; Fortin LJ; Dubreuil D; Marcoux C; Davignon J; Lussier-Cacan S
    J Lab Clin Med; 2003 Jan; 141(1):41-9. PubMed ID: 12518167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
    Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composition of LDL as determinant of its susceptibility to in vitro oxidation in patients with well-controlled type 2 diabetes.
    Scheffer PG; Bakker SJ; Popp-Snijders C; Heine RJ; Schutgens RB; Teerlink T
    Diabetes Metab Res Rev; 2001; 17(6):459-66. PubMed ID: 11757082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD.
    Roob JM; Rabold T; Hayn M; Khoschsorur G; Resch U; Holzer H; Winklhofer-Roob BM
    Kidney Int Suppl; 2001 Feb; 78():S128-36. PubMed ID: 11168998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal prostaglandinuria E2 in Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome.
    Lüthy C; Bettinelli A; Iselin S; Metta MG; Basilico E; Oetliker OH; Bianchetti MG
    Am J Kidney Dis; 1995 Jun; 25(6):824-8. PubMed ID: 7771477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia.
    Blom HJ; Kleinveld HA; Boers GH; Demacker PN; Hak-Lemmers HL; Te Poele-Pothoff MT; Trijbels JM
    Eur J Clin Invest; 1995 Mar; 25(3):149-54. PubMed ID: 7781660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content.
    Tribble DL; van den Berg JJ; Motchnik PA; Ames BN; Lewis DM; Chait A; Krauss RM
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1183-7. PubMed ID: 8302851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.
    Fuller CJ; Grundy SM; Norkus EP; Jialal I
    Atherosclerosis; 1996 Jan; 119(2):139-50. PubMed ID: 8808491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of n-3 fatty acid-rich fish oil supplementation on the oxidation of low density lipoproteins.
    Frankel EN; Parks EJ; Xu R; Schneeman BO; Davis PA; German JB
    Lipids; 1994 Apr; 29(4):233-6. PubMed ID: 8177016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.